China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Symbol: 000999.SZ
SHZ
60.44
CNYMarktpreis heute
19.3562
P/E-Verhältnis
0.6713
PEG-Verhältnis
59.16B
MRK Kapital
- 0.02%
DIV Rendite
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999-SZ) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 31131.85 | 8226.8 | 3149.7 | 4283.9 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 4438.4 | 1873.3 | -2647.1 | 1218.8 | |||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 35661.86 | 8581.2 | 6071.3 | 5659.4 | |||||||||||||||||||||||||||
balance-sheet.row.inventory | 19561.08 | 5112.5 | 2498.9 | 2308.5 | |||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 2087.77 | 601.5 | 268.6 | 226.6 | |||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 88442.55 | 22522 | 11988.5 | 12478.4 | |||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 26485.4 | 6802.6 | 4823 | 4237.8 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill | 20610.44 | 5123.9 | 3994.9 | 4060.4 | |||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 16356.23 | 4078.3 | 2749.9 | 2646.6 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 36966.68 | 9202.2 | 6744.7 | 6707 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2002.87 | 724.9 | 2948.1 | -980.1 | |||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 2492.53 | 626.8 | 324.5 | 241.4 | |||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 2569.73 | 270 | 293.9 | 1623.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 70517.2 | 17626.5 | 15134.3 | 11829.6 | |||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-assets | 158959.75 | 40148.5 | 27122.8 | 24308 | |||||||||||||||||||||||||||
balance-sheet.row.account-payables | 10661.5 | 2365.2 | 1795.1 | 1415.8 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 6351.27 | 2019.9 | 235.1 | 110.7 | |||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 1709.78 | 254.5 | 518.1 | 373.9 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 7337.29 | 1802.9 | 156 | 96.7 | |||||||||||||||||||||||||||
Deferred Revenue Non Current | 2242.3 | 455.5 | 423.2 | 395.1 | |||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1527.48 | - | - | - | |||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 14138.21 | 6911.7 | 5630.2 | 234.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 11689.15 | 2474.3 | 916.7 | 819.8 | |||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 494.4 | 119.5 | 105.8 | 88.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-liab | 61904.84 | 15421.2 | 9589.4 | 8595.3 | |||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.common-stock | 3952.9 | 988.2 | 988.3 | 978.9 | |||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 62863.05 | 16047.3 | 13761.4 | 12131.5 | |||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 6444.97 | 754.6 | 673.1 | 549.3 | |||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2509.22 | 1177 | 1586.7 | 1622.9 | |||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 75770.14 | 18967.1 | 17009.6 | 15282.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 158959.75 | 40148.5 | 27122.8 | 24308 | |||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 20819.42 | 5294.7 | 523.8 | 430.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-equity | 96589.56 | 24261.9 | 17533.4 | 15712.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 158959.75 | - | - | - | |||||||||||||||||||||||||||
Total Investments | 6441.27 | 2598.3 | 301 | 238.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-debt | 13908.27 | 3942.3 | 391.1 | 207.4 | |||||||||||||||||||||||||||
balance-sheet.row.net-debt | -12785.17 | -2411.2 | -2758.6 | -2857.7 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 3065.73 | 2852.9 | 2497 | 2080.8 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 54.35 | 853.7 | 522.7 | 476.2 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -74.4 | -137.7 | -63.5 | -87 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 82.91 | -1724.5 | 63.5 | 87 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -332.32 | -17 | -216.9 | -946.9 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 633.69 | 633.7 | -71.8 | -674.7 | |||||||||||||||||||||||||
cash-flows.row.inventory | -966.01 | -966 | -59.7 | -664.9 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 315.3 | -21.9 | 458.4 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -63.5 | -65.7 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 1989.6 | 2393 | 203.5 | 260.3 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 4707.2 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -780.38 | -857.2 | -951.6 | -870.8 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 25.56 | 31.1 | -11.8 | -120.6 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -4195.27 | -3182 | -5675.9 | -5203.2 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 2908.42 | 2228.6 | 4152.1 | 4394.8 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -284.8 | 957.8 | 8 | 9.3 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2326.47 | -821.7 | -2479.2 | -1790.5 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | -1446.58 | -1741.8 | -462.2 | -28.5 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0.28 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.28 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | -1076.37 | -988.3 | -855.8 | -491.8 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 3351.22 | 3180.1 | 742.5 | -132.8 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -97.65 | 450 | -575.5 | -653.1 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 4.94 | 5 | 6.3 | -2.3 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 2101.65 | 3203.7 | -41.9 | -575.4 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 25499.51 | 6353.5 | 2361.4 | 2403.2 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 23397.85 | 3149.7 | 2403.4 | 2978.7 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 4707.2 | 4220.4 | 3006.4 | 1870.5 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -780.38 | -857.2 | -951.6 | -870.8 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 3926.82 | 3363.2 | 2054.8 | 999.7 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 25524.28 | 24464 | 18079.5 | 15320 | |||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 12125.74 | 11859.7 | 8313.1 | 6170.8 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 13398.55 | 12604.4 | 9766.3 | 9149.2 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.research-development | 700.37 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 380.93 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 7123.52 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -161.15 | -108.2 | 792.5 | 662.2 | |||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 9498.49 | 9080.3 | 6717 | 6497.6 | |||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 21624.23 | 20940 | 15030.2 | 12668.4 | |||||||||||||||||||||||||||
income-statement-row.row.interest-income | 76.05 | 106.9 | 73.5 | 67 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 91.89 | 80.8 | 21.2 | 13.3 | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 7123.52 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 192.28 | 225.2 | 16.2 | -28.4 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -161.15 | -108.2 | 792.5 | 662.2 | |||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 192.28 | 225.2 | 16.2 | -28.4 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 91.89 | 80.8 | 21.2 | 13.3 | |||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 510.85 | 853.7 | 704 | 729.5 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 4353.5 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.operating-income | 3856.84 | 3524 | 2947.2 | 2457.4 | |||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 4049.12 | 3749.2 | 2963.4 | 2429.1 | |||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 650.56 | 581 | 466.4 | 348.2 | |||||||||||||||||||||||||||
income-statement-row.row.net-income | 3065.73 | 2852.9 | 2448.8 | 2055.1 |
Häufig gestellte Frage
Wie hoch ist die China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) Gesamtvermögen?
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) Gesamtvermögen ist 40148455933.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 13268686742.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.525.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 4.011.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.120.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.151.
Was ist der China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 2852931664.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 3942294961.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 9080313650.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 7026231386.000.